These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12946058)

  • 1. Gene therapy for Parkinson's disease.
    Mochizuki H; Mizuno Y
    J Neural Transm Suppl; 2003; (65):205-13. PubMed ID: 12946058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.
    Mochizuki H; Hayakawa H; Migita M; Shibata M; Tanaka R; Suzuki A; Shimo-Nakanishi Y; Urabe T; Yamada M; Tamayose K; Shimada T; Miura M; Mizuno Y
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10918-23. PubMed ID: 11535810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors.
    Ozawa K; Fan DS; Shen Y; Muramatsu S; Fujimoto K; Ikeguchi K; Ogawa M; Urabe M; Kume A; Nakano I
    J Neural Transm Suppl; 2000; (58):181-91. PubMed ID: 11128607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein.
    Suzuki A; Obi K; Urabe T; Hayakawa H; Yamada M; Kaneko S; Onodera M; Mizuno Y; Mochizuki H
    J Neurochem; 2002 Aug; 82(4):953-60. PubMed ID: 12358801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
    Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
    Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus-mediated antiapoptotic gene delivery: in vivo gene therapy for neurological disorders.
    Mochizuki H; Miura M; Shimada T; Mizuno Y
    Methods; 2002 Oct; 28(2):248-52. PubMed ID: 12413423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for Parkinson's disease.
    Horellou P; Mallet J
    Mol Neurobiol; 1997 Oct; 15(2):241-56. PubMed ID: 9396012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy and cell transplantation for Parkinson's disease].
    Muramatsu S
    Rinsho Shinkeigaku; 2005 Nov; 45(11):902-4. PubMed ID: 16447758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.
    Cederfjäll E; Sahin G; Kirik D; Björklund T
    Mol Ther; 2012 Jul; 20(7):1315-26. PubMed ID: 22294150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [AAV vector-mediated gene transfer and its application to the nervous system].
    Ozawa K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):835-8. PubMed ID: 15152479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
    Björklund T; Carlsson T; Cederfjäll EA; Carta M; Kirik D
    Brain; 2010 Feb; 133(Pt 2):496-511. PubMed ID: 20129936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease.
    Bankiewicz KS; Leff SE; Nagy D; Jungles S; Rokovich J; Spratt K; Cohen L; Libonati M; Snyder RO; Mandel RJ
    Exp Neurol; 1997 Mar; 144(1):147-56. PubMed ID: 9126164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Bankiewicz KS; Eberling JL; Kohutnicka M; Jagust W; Pivirotto P; Bringas J; Cunningham J; Budinger TF; Harvey-White J
    Exp Neurol; 2000 Jul; 164(1):2-14. PubMed ID: 10877910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient early and sustained transduction of human fetal mesencephalon using adeno-associated virus type 2 vectors.
    Tenenbaum L; Peschanski M; Melas C; Rodesh F; Lehtonen E; Stathopoulos A; Velu T; Brotchi J; Levivier M
    Cell Transplant; 2004; 13(5):565-71. PubMed ID: 15565868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of gene therapy for Parkinson's disease].
    Mochizuki H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):753-5. PubMed ID: 20030202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?
    Brown N; Song L; Kollu NR; Hirsch ML
    Hum Gene Ther; 2017 Jun; 28(6):450-463. PubMed ID: 28490211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.